L-Sulpiride in young and elderly negative schizophrenics: Clinical and pharmacokinetic variables

Abstract

1. Clinical activity, tolerability and kinetic profile of L-sulpiride (200–300 mg/die p.o.) in relation to age, in 14 chronic schizophrenic in patients diagnosed according to DSM III-R, typed as negative forms, were studied. 2. The drug showed Its efficacy in negative forms of schizophrenia, without any significant difference between negative and positive symptoms even if productive symptom scores were quite low already in pre-treatment condition. 3. No more side effects (anticholinergic and extrapyramidal) in elderly patients compared to young/adult ones were reported. 4. No significant differences between young/adult and elderly patients for the various pharmacokinetic parameters (t 1 2 , AUC, Cmax, Tmax, Vd and CI), after acute and multiple dosing, were observed.